Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hugh

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Diabetes Care|June 29, 2011
Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetesChristina Wang, Graham Jackson, T Hugh Jones, et al.
Life Sciences|June 24, 2014
Testosterone suppresses the expression of regulatory enzymes of fatty acid synthesis and protects against hepatic steatosis in cholesterol-fed androgen deficient miceDaniel M Kelly, Joanne E Nettleship, Samia Akhtar, et al.
The World Journal of Men'S Health|March 6, 2023
The British Society for Sexual Medicine Guidelines on Male Adult Testosterone Deficiency, with Statements for PracticeGeoffrey Hackett, Michael Kirby, Rowland W Rees, et al.
Diabetes Care|March 10, 2011
Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study)T Hugh Jones, Stefan Arver, Hermann M Behre, et al.
Endocrine|February 4, 2018
Metabolic phenotype of male obesity-related secondary hypogonadism pre-replacement and post-replacement therapy with intra-muscular testosterone undecanoate therapyGeorgios K Dimitriadis, Harpal S Randeva, Saboor Aftab, et al.
Endocrinology, Diabetes & Metabolism|July 12, 2019
Male hypogonadism: 14-year prospective outcome in 550 men with type 2 diabetesNagaraj S Malipatil, Ghasem Yadegarfar, Mark Lunt, et al.
Scientific Reports|February 13, 2021
Phylogenomics reveals viral sources, transmission, and potential superinfection in early-stage COVID-19 patients in Ontario, CanadaCalvin P Sjaarda, Nazneen Rustom, Gerald A Evans, et al.
The Journal of Clinical Endocrinology and Metabolism|December 13, 2003
Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomasDamian G Morris, Blerina Kola, Ninetta Borboli, et al.
Mayo Clinic Proceedings|June 18, 2016
Fundamental Concepts Regarding Testosterone Deficiency and Treatment: International Expert Consensus ResolutionsAbraham Morgentaler, Michael Zitzmann, Abdulmaged M Traish, et al.
European Urology|June 29, 2021
European Association of Urology Guidelines on Sexual and Reproductive Health-2021 Update: Male Sexual DysfunctionAndrea Salonia, Carlo Bettocchi, Luca Boeri, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Diabetes Care|June 29, 2011
Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetesChristina Wang, Graham Jackson, T Hugh Jones, et al.
Life Sciences|June 24, 2014
Testosterone suppresses the expression of regulatory enzymes of fatty acid synthesis and protects against hepatic steatosis in cholesterol-fed androgen deficient miceDaniel M Kelly, Joanne E Nettleship, Samia Akhtar, et al.
The World Journal of Men'S Health|March 6, 2023
The British Society for Sexual Medicine Guidelines on Male Adult Testosterone Deficiency, with Statements for PracticeGeoffrey Hackett, Michael Kirby, Rowland W Rees, et al.
Diabetes Care|March 10, 2011
Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study)T Hugh Jones, Stefan Arver, Hermann M Behre, et al.
Endocrine|February 4, 2018
Metabolic phenotype of male obesity-related secondary hypogonadism pre-replacement and post-replacement therapy with intra-muscular testosterone undecanoate therapyGeorgios K Dimitriadis, Harpal S Randeva, Saboor Aftab, et al.
Endocrinology, Diabetes & Metabolism|July 12, 2019
Male hypogonadism: 14-year prospective outcome in 550 men with type 2 diabetesNagaraj S Malipatil, Ghasem Yadegarfar, Mark Lunt, et al.
Scientific Reports|February 13, 2021
Phylogenomics reveals viral sources, transmission, and potential superinfection in early-stage COVID-19 patients in Ontario, CanadaCalvin P Sjaarda, Nazneen Rustom, Gerald A Evans, et al.
The Journal of Clinical Endocrinology and Metabolism|December 13, 2003
Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomasDamian G Morris, Blerina Kola, Ninetta Borboli, et al.
Mayo Clinic Proceedings|June 18, 2016
Fundamental Concepts Regarding Testosterone Deficiency and Treatment: International Expert Consensus ResolutionsAbraham Morgentaler, Michael Zitzmann, Abdulmaged M Traish, et al.
European Urology|June 29, 2021
European Association of Urology Guidelines on Sexual and Reproductive Health-2021 Update: Male Sexual DysfunctionAndrea Salonia, Carlo Bettocchi, Luca Boeri, et al.
Pageof 10